TIFFANY TERRA: Open Payments
NPI 1689013427 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$576 in 34 payments from 17 companies in 2025. Trend: 2023 $778 · 2024 $301 · 2025 $576
Food & beverage: $576
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $146 |
| Vanda Pharmaceuticals Inc. | 4 | $71 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| Supernus Pharmaceuticals, Inc. | 2 | $35 |
| Novo Nordisk Inc | 2 | $35 |
| Astellas Pharma US Inc | 2 | $30 |
| ABIOMED | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Corium, LLC | 1 | $22 |
| Antares Pharma, Inc. | 1 | $20 |
Products named: VRAYLAR, FANAPT, Auvelity, Qelbree, Veozah, CAPLYTA, Azstarys, XYOSTED.
Industry payments across LA — which companies pay providers there.
